{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:59:45Z","timestamp":1784221185703,"version":"3.55.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T00:00:00Z","timestamp":1523404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,13]]},"abstract":"<jats:p>Enzyme-linked immunosorbent and microneutralization assays of 180 Ebola convalescent plasma specimens were highly concordant and predictive for detection of antibody by 50% plaque reduction neutralization test. Viral load decreased following infusion of antibody-containing plasma in 2 Ebola virus disease patients.<\/jats:p>","DOI":"10.1093\/infdis\/jiy199","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:15:27Z","timestamp":1522797327000},"page":"555-562","source":"Crossref","is-referenced-by-count":34,"title":["Anti\u2013Ebola Virus Antibody Levels in Convalescent Plasma and Viral Load After Plasma Infusion in Patients With Ebola Virus Disease"],"prefix":"10.1093","volume":"218","author":[{"given":"Jerry F","family":"Brown","sequence":"first","affiliation":[{"name":"Eternal Love Winning Africa Hospital, Paynesville, Liberia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Dye","sequence":"additional","affiliation":[{"name":"US Army Medical Research Institute of Infectious Disease, Frederick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Tozay","sequence":"additional","affiliation":[{"name":"Eternal Love Winning Africa Hospital, Paynesville, Liberia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gertrude","family":"Jeh-Mulbah","sequence":"additional","affiliation":[{"name":"Eternal Love Winning Africa Hospital, Paynesville, Liberia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Wohl","sequence":"additional","affiliation":[{"name":"University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"2nd","given":"William A","family":"Fischer","sequence":"additional","affiliation":[{"name":"University of North Carolina School of Medicine, Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coleen K","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Rowe","sequence":"additional","affiliation":[{"name":"Blood Centers of America, West Warwick, Rhode Island"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zacharias","sequence":"additional","affiliation":[{"name":"Safe Blood for Africa Foundation, Washington, District of Columbia, Hinckley, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"van Hasselt","sequence":"additional","affiliation":[{"name":"Safe Blood for Africa Foundation, Washington, District of Columbia, Hinckley, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Norwood","sequence":"additional","affiliation":[{"name":"US Army Medical Research Institute of Infectious Disease, Frederick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan M","family":"Thielman","sequence":"additional","affiliation":[{"name":"Duke University School of Medicine, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha E","family":"Zak","sequence":"additional","affiliation":[{"name":"US Army Medical Research Institute of Infectious Disease, Frederick, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"Hoover","sequence":"additional","affiliation":[{"name":"Clinical Research Management, Inc, Hinckley, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,4,11]]},"reference":[{"key":"2019120301004805000_CIT0001","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/7422","article-title":"Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients","volume":"5","author":"Baize","year":"1999","journal-title":"Nat Med"},{"key":"2019120301004805000_CIT0002","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1056\/NEJM197511202932102","article-title":"Clinical trials of hepatitis B immune globulin. Development of policies and materials for the 1972-1975 studies sponsored by the National Heart and Lung Institute","volume":"293","author":"Surgenor","year":"1975","journal-title":"N Engl J Med"},{"key":"2019120301004805000_CIT0003","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2019120301004805000_CIT0004","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Intern Med"},{"key":"2019120301004805000_CIT0005","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(79)92335-3","article-title":"Efficacy of immune plasma in treatment of Argentine haemorrhagic fever and association between treatment and a late neurological syndrome","volume":"2","author":"Maiztegui","year":"1979","journal-title":"Lancet"},{"key":"2019120301004805000_CIT0006","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"key":"2019120301004805000_CIT0007","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1086\/514298","article-title":"Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee","volume":"179","author":"Mupapa","year":"1999","journal-title":"J Infect Dis"},{"key":"2019120301004805000_CIT0008","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jca.21482","article-title":"Apheresis for collection of Ebola convalescent plasma in Liberia","volume":"32","author":"Brown","year":"2017","journal-title":"J Clin Apher"},{"key":"2019120301004805000_CIT0009","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.celrep.2016.04.026","article-title":"Antibody treatment of Ebola and Sudan virus infection via a uniquely exposed epitope within the glycoprotein receptor-binding site","volume":"15","author":"Howell","year":"2016","journal-title":"Cell Rep"},{"key":"2019120301004805000_CIT0010","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4269\/ajtmh.2010.09-0636","article-title":"Comprehensive panel of real-time TaqMan polymerase chain reaction assays for detection and absolute quantification of filoviruses, arenaviruses, and New World hantaviruses","volume":"82","author":"Trombley","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"2019120301004805000_CIT0011","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMc1609116","article-title":"Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies","volume":"375","author":"van Griensven","year":"2016","journal-title":"N Engl J Med"},{"key":"2019120301004805000_CIT0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Evaluation of convalescent plasma for Ebola virus disease in Guinea","volume":"374","author":"van Griensven","year":"2016","journal-title":"N Engl J Med"},{"key":"2019120301004805000_CIT0013","doi-asserted-by":"crossref","first-page":"e1001997","DOI":"10.1371\/journal.pmed.1001997","article-title":"Experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial","volume":"13","author":"Dunning","year":"2016","journal-title":"PLoS Med"},{"key":"2019120301004805000_CIT0014","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","article-title":"A randomized, controlled trial of ZMapp for Ebola virus infection","volume":"375","author":"PREVAIL II Writing Group; Multi-National PREVAIL II Study Team","year":"2016","journal-title":"N Engl J Med"},{"key":"2019120301004805000_CIT0015","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with favipiravir for Ebola virus disease (the JIKI Trial): a historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"Sissoko","year":"2016","journal-title":"PLoS Med"},{"key":"2019120301004805000_CIT0016","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JVI.78.8.4330-4341.2004","article-title":"Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome","volume":"78","author":"Towner","year":"2004","journal-title":"J Virol"},{"key":"2019120301004805000_CIT0017","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa1411680","article-title":"Clinical illness and outcomes in patients with Ebola in Sierra Leone","volume":"371","author":"Schieffelin","year":"2014","journal-title":"N Engl J Med"},{"key":"2019120301004805000_CIT0018","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1172\/JCI83162","article-title":"Ebola viral load at diagnosis associates with patient outcome and outbreak evolution","volume":"125","author":"de La Vega","year":"2015","journal-title":"J Clin Invest"},{"key":"2019120301004805000_CIT0019","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/infdis\/jiv304","article-title":"The contribution of Ebola viral load at admission and other patient characteristics to mortality in a Medecins Sans Frontieres Ebola case management centre, Kailahun, Sierra Leone, June-October 2014","volume":"212","author":"Fitzpatrick","year":"2015","journal-title":"J Infect Dis"},{"key":"2019120301004805000_CIT0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijid.2015.10.021","article-title":"Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients","volume":"42","author":"Li","year":"2016","journal-title":"Int J Infect Dis"},{"key":"2019120301004805000_CIT0021","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.1200409109","article-title":"Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease","volume":"109","author":"Dye","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019120301004805000_CIT0022","doi-asserted-by":"crossref","first-page":"S400","DOI":"10.1086\/520587","article-title":"Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates","volume":"196","author":"Jahrling","year":"2007","journal-title":"J Infect Dis"},{"key":"2019120301004805000_CIT0023","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/infdis\/jiw333","article-title":"Passive immunotherapy: assessment of convalescent serum against Ebola virus Makona infection in nonhuman primates","volume":"214","author":"Mire","year":"2016","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/4\/555\/31191318\/jiy199.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/218\/4\/555\/31191318\/jiy199.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T01:02:44Z","timestamp":1575334964000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/218\/4\/555\/4967721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,11]]},"references-count":23,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4,11]]},"published-print":{"date-parts":[[2018,7,13]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy199","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8,15]]},"published":{"date-parts":[[2018,4,11]]}}}